Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods (Q39673650)

13 September 2017

1 reference

title

Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods (English)

1 reference

13 September 2017

Gram-negative bacteria

0 references

author name string

D M Livermore

series ordinal

1

1 reference

13 September 2017

1 August 1987

1 reference

European journal of clinical microbiology

13 September 2017

1 reference

13 September 2017

6

1 reference

13 September 2017

439-445

1 reference

13 September 2017

4

1 reference

Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.

13 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FBF02013107

Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013107

Role of beta-lactam hydrolysis in the mechanism of resistance of a beta-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum beta-lactams

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013107

Beta-lactamase lability and inducer power of newer beta-lactam antibiotics in relation to their activity against beta-lactamase-inducibility mutants of Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013107

Interaction of azthreonam and related monobactams with beta-lactamases from gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013107

Induction kinetics of beta-lactamase biosynthesis in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013107

Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013107

Mutants of Pseudomonas aeruginosa with impaired -lactamase inducibility and increased sensitivity to -lactam antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013107

Kinetic studies on the inhibition of Proteus vulgaris beta-lactamase by imipenem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013107

Effect of clavulanic acid on the activity of ticarcillin against Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013107

Microbial resistance to newer generation beta-lactam antibiotics: clinical and laboratory implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013107

Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013107

Influence of clindamycin on derepression of beta-lactamases in Enterobacter spp. and Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013107

Beta-lactamase induction and derepression.

21 January 2018

1 reference

12 December 2020

Class I beta-lactamase expression in Pseudomonas aeruginosa and cephalosporin resistance

1 reference

12 December 2020

The beta-lactamases of gram-negative bacteria and their possible physiological role.

1 reference

12 December 2020

Antibacterial antagonism of beta-lactam antibiotics in experimental infections

1 reference

12 December 2020

Cephalosporin resistance in Pseudomonas aeruginosa, with special reference to the proposed trapping of antibiotics by beta-lactamase.

1 reference

12 December 2020

The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics

1 reference

12 December 2020

Beta-lactams and imipenem.

1 reference

12 December 2020

Regulatory components in Citrobacter freundii ampC beta-lactamase induction

1 reference

12 December 2020

Characterization of eight beta-lactamases of Gram-negative bacteria.

1 reference

12 December 2020

Thiolactomycin, a new antibiotic. III. In vitro antibacterial activity.

1 reference

12 December 2020

Genetic and biochemical basis of resistance of Enterobacteriaceae to beta-lactam antibiotics.

1 reference

12 December 2020

Inducible beta-lactamases are principally responsible for the naturally occurring resistance towards beta-lactam antibiotics in Proteus vulgaris

1 reference

12 December 2020

Kinetics and significance of the activity of the Sabath and Abrahams' beta-lactamase of Pseudomonas aeruginosa against cefotaxime and cefsulodin.

1 reference

12 December 2020

Effects of inducible beta-lactamase and antimicrobial resistance upon the activity of newer beta-lactam antibiotics against Pseudomonas aeruginosa.

1 reference

12 December 2020

Nonspecific Induction of -lactamase in Enterobacter cloacae

1 reference

12 December 2020

Mechanisms of beta-lactam resistance in British isolates of Pseudomonas aeruginosa.

1 reference

12 December 2020

Induction of beta-lactamase in Proteus vulgaris

1 reference

12 December 2020

Pseudomonas aeruginosa beta-lactamase as a defence against azlocillin, mezlocillin and piperacillin.

1 reference

12 December 2020

Contribution of chromosomal beta-lactamases to beta-lactam resistance in enterobacteria.

1 reference

12 December 2020

Selection of variants of Gram-negative bacteria with elevated production of type 1 beta-lactamase

1 reference

12 December 2020

Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics

1 reference

12 December 2020

Specificity of beta-lactamase induction in Pseudomonas aeruginosa.

1 reference

12 December 2020

Do beta-lactamases 'trap' cephalosporins?

1 reference

12 December 2020

Inducible type I beta-lactamases of gram-negative bacteria and resistance to beta-lactam antibiotics.

1 reference

12 December 2020

Cefpirome (HR 810): lack of selection of beta-lactamase overproducing variants

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02013107

1 reference

13 September 2017

1 reference

PubMed ID

3311738